This Randomised Controlled Trial (RCT) will compare a CMT intervention for people with Type 1 and Type 2 Diabetes Mellitus with a waitlist control group who will be given access after the study.
The outcome measures will be completed at baseline (week 0), post-intervention (week 4), and at follow-up (week 8).
